- Article number:
- 1672 -0571( 2019) 04 -0130 -04
- ZTFLH:
- R285.5
- Code:
- A
References:
[1]邱晓星,彭清华,陈梅,等.蛴螬提取物对兔脉络膜新生血管中Ang1和PEDF表达的影响[J].国际眼科杂志,2012,12(11):2053-2058.
[2]张波涛,彭清华,叶群如,等.蛴螬提取物对兔视网膜静脉阻塞模型视网膜组织ET-1表达的影响[J].湖南中医药大学学报,2012,32(9):8-11.
[3]阳长明,侯世祥,罗英杰,等.蛴螬滴眼液中氨基酸成分的测定[J].湖南中医杂志,2001,32(1):57-59.
[4]陈立军,王雨生.“二步法”激光诱导脉络膜视网膜静脉吻合术治疗兔视网膜中央静脉阻塞的视觉电生理变化[J].眼科新进展,2006,26(4):253.
[5]唐坤,李素芬.视网膜分支静脉阻塞无灌注区范围?视野阈值与新生血管关系的研究[J].国际眼科杂志,2009,9(6):15-16.
[6] Wolf - Schnurrbusch U E K. Retinal Vein Occlusion[ M] / / Spectral Domain Optical Coherence Tomography inMacular Diseases. Springer, New Delhi, 2017: 147-150.
[7] Goldenberg D, Loewenstein A. Retinal Vein Occlusion[ M] / / Medical Retina. Karger Publishers, 2017,9: 32 -41.
[8] Jonas J B, Monés J, Glacet - Bernard A, et al. Retinalvein occlusions[ M] / / Macular Edema. Karger Publishers,2017,8: 139 -167.
[9] Starr M R, Norby S M, Scott J P, et al. Acute retinal veinocclusion and cystic fibrosis[ J] . International journal ofretina and vitreous, 2018, 4( 1) : 26.
[10] Prajapati V A, Vasavada D, Patel S M, et al. A study ofevaluation of various risk factors of retinal vein occlusion[ J] . International Journal of Research in Medical Sciences, 2017, 2( 3) : 1054 -1057.
[11] Bucciarelli P, Passamonti S M, Gianniello F, et al.Thrombophilic and cardiovascular risk factors for retinalvein occlusion[ J] . European journal of internal medicine,2017, 44: 44 -48.
[12] Winegarner A, Wakabayashi T, Hara - Ueno C, et al.Retinal microvasculature and visual acuity after intravitrealaflibercept in eyes with central retinal vein occlusion: anoptical coherence tomography angiography study[ J] . Retina, 2018, 38( 10) : 2067 -2072.
[13]何茂秋,董玉.视网膜静脉阻塞的中西医治疗进展[J].云南中医中药杂志,2018,39(10):70-72.
[14] Suna N I, Liu J. Expressions of MMPs, TIMPs and TLRin the fetal membrane tissues of patients with PROM[ J] .Hebei Medical Journal, 2018.
[15] Carpio L R, Bradley E W, Westendorf J J. Histonedeacetylase 3 suppresses Erk phosphorylation and matrixmetalloproteinase ( Mmp) - 13 activity in chondrocytes [J] . Connective tissue research, 2017, 58( 1) : 27 -36.
[16] Manicone A M, Gharib S A, Gong K Q, et al. MatrixMetalloproteinase - 28 is a key contributor to emphysemapathogenesis[ J] . The American journal of pathology,2017, 187( 6) : 1288 -1300.
[17] Lebre M C, Vieira P L, Tang M W, et al. Synovial IL- 21/ TNF- producing CD4 + T cells induce joint destruction in rheumatoid arthritis by inducing matrix metalloproteinase production by fibroblast ? like synoviocytes[ J] . Journal of leukocyte biology, 2017, 101( 3) : 775 -783.
[18] Naveed S, Clements D, Jackson D J, et al. Matrix metalloproteinase - 1 activation contributes to airway smoothmuscle growth and asthma severity [ J] . American journalof respiratory and critical care medicine, 2017, 195( 8) :1000 -1009.
Memo
国家自然科学基金面上项目（３０７７２８２４，８１５７４０３１）；中医药防治五官科疾病湖南省重点实验室建设项目 （２０１７ＴＰ１０１８）；长沙市科技计划项目（Ｋ１５０１０１４－３１，ｋｃ１７０４００５）；中央财政支持地方高校建设项目；国家 中医药管理局中医眼科学重点学科建设项目；湖南省中医五官科学重点学科建设项目